ArticleACS medicinal chemistry letters2021

Discovery of Imidazopyridines as Potent Inhibitors of Indoleamine 2,3-Dioxygenase 1 for Cancer Immunotherapy.

Liping Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.